Comparing 3T and 1.5T MRI for Mapping Hippocampal Atrophy in the Alzheimer's Disease Neuroimaging Initiative

^aFrom the School of Medicine (N.C.), University of California, Irvine, Irvine, California
^bOakland University William Beaumont School of Medicine (K.S.H.), Rochester Hills, Michigan
^cDepartments of Neurology (K.S.H., S.H., L.G.A.)
^dBiostatistics (D.A.E.), University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
^eDepartment of Physiology (A.E.G.), Monash University, Melbourne, Australia
^fDepartment of Neurology (J.H.S.), Cruces University Hospital, Barakaldo, Spain
^gImaging Genetics Center (P.M.T.), Institute for Neuroimaging and Informatics, Keck/University of Southern California School of Medicine, Los Angeles, California
^hDepartments of Neurology, Psychiatry, Engineering, Radiology, and Ophthalmology (P.M.T.), University of Southern California, Los Angeles, California
ⁱDepartment of Radiology (C.R.J.), Mayo Clinic and Foundation, Rochester, Minnesota
^jDepartment of Radiology and Biomedical Imaging (M.W.), University of California, San Francisco, School of Medicine, San Francisco, California.

Please address correspondence to Liana G. Apostolova, MD, MSCR, Mary S. Easton Center for Alzheimer's Disease Research, 10911 Weyburn Ave, 2nd floor, Los Angeles, CA 90095; e-mail: lapostolova{at}mednet.ucla.edu